ArticleBreast cancer research and treatment2012

Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor.

Xianke Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.